246 related articles for article (PubMed ID: 23486875)
1. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers.
Jeppsson A; Zetterberg H; Blennow K; Wikkelsø C
Neurology; 2013 Apr; 80(15):1385-92. PubMed ID: 23486875
[TBL] [Abstract][Full Text] [Related]
2. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
[TBL] [Abstract][Full Text] [Related]
3. Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus.
Jeppsson A; Höltta M; Zetterberg H; Blennow K; Wikkelsø C; Tullberg M
Fluids Barriers CNS; 2016 Jul; 13(1):13. PubMed ID: 27472944
[TBL] [Abstract][Full Text] [Related]
4. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus.
Agren-Wilsson A; Lekman A; Sjöberg W; Rosengren L; Blennow K; Bergenheim AT; Malm J
Acta Neurol Scand; 2007 Nov; 116(5):333-9. PubMed ID: 17922727
[TBL] [Abstract][Full Text] [Related]
5. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
Kang K; Ko PW; Jin M; Suk K; Lee HW
J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
Lukkarinen H; Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Hiltunen M; Rauramaa T; Nägga K; Leinonen V; Tullberg M
Fluids Barriers CNS; 2022 Feb; 19(1):11. PubMed ID: 35123528
[TBL] [Abstract][Full Text] [Related]
9. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarkers in cardiac arrest survivors.
Rosén C; Rosén H; Andreasson U; Bremell D; Bremler R; Hagberg L; Rosengren L; Blennow K; Zetterberg H
Resuscitation; 2014 Feb; 85(2):227-32. PubMed ID: 24231570
[TBL] [Abstract][Full Text] [Related]
13. Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus.
Tarnaris A; Toma AK; Chapman MD; Keir G; Kitchen ND; Watkins LD
J Neurosurg; 2011 Jul; 115(1):145-50. PubMed ID: 21438653
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
Chen Z; Liu C; Zhang J; Relkin N; Xing Y; Li Y
Fluids Barriers CNS; 2017 May; 14(1):13. PubMed ID: 28486988
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: a discrimination from Alzheimer's disease.
Kapaki EN; Paraskevas GP; Tzerakis NG; Sfagos C; Seretis A; Kararizou E; Vassilopoulos D
Eur J Neurol; 2007 Feb; 14(2):168-73. PubMed ID: 17250725
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
[TBL] [Abstract][Full Text] [Related]
17. Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus.
Grønning R; Jeppsson A; Hellström P; Laurell K; Farahmand D; Zetterberg H; Blennow K; Wikkelsø C; Tullberg M
Fluids Barriers CNS; 2023 Oct; 20(1):77. PubMed ID: 37880775
[TBL] [Abstract][Full Text] [Related]
18. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau.
Ray B; Reyes PF; Lahiri DK
J Psychiatr Res; 2011 Apr; 45(4):539-47. PubMed ID: 20828718
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus.
Nakajima M; Miyajima M; Ogino I; Akiba C; Sugano H; Hara T; Fusegi K; Karagiozov K; Arai H
J Neurol Sci; 2015 Oct; 357(1-2):88-95. PubMed ID: 26169158
[TBL] [Abstract][Full Text] [Related]
20. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
Jingami N; Uemura K; Asada-Utsugi M; Kuzuya A; Yamada S; Ishikawa M; Kawahara T; Iwasaki T; Atsuchi M; Takahashi R; Kinoshita A
J Alzheimers Dis; 2019; 72(1):271-277. PubMed ID: 31561378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]